Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AEGERION PHARMA (NQ: AEGR)
60.09 USD  -0.87 (-1.43%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Stories about AEGERION PHARMA
 
< Previous 1 2 3 4 5 Next >
Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q4 Loss of 86c/Share
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8160471 for the full story. Read More
from StreetInsider.com News Articles
Earnings Scheduled For March 6, 2013
March 06, 2013
American Eagle Outfitters (NYSE: AEO ) is estimated to report its Q4 earnings at $0.56 per share on revenue of $1.12 billion. Big Lots (NYSE: BIG ) is projected to report its Q4 earnings at $1.98 per... Read More
category Earnings , ACW , BIG , and 46 more.
from Latest Articles from Benzinga.com
BofA/Merrill Lynch Starts Aegerion Pharmaceuticals (AEGR) at Buy
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8155173 for the full story. Read More
from StreetInsider.com News Articles
Study Casts Doubt On Value Of Genetic Testing For Familial Hypercholesterolemia
February 21, 2013
The recent introduction of two drugs (lomitapide from Aegerion and mipomersen from Isis and Sanofi) specifically targeted to treat people with the rare but dangerous condition of homozygous familial... Read More
category NYSE:SNY , EURONEXTPARIS:SNY , NASDAQ:ISIS , and 1 more.
from Forbes Real Time
Lazard Capital Upgrades Aegerion Pharmaceuticals (AEGR) to Buy
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8076854 for the full story. Read More
from StreetInsider.com News Articles
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
January 29, 2013
The FDA said today that it had granted approval to the novel cholesterol-lowering drug mipomersen sodium for use as an adjunct to diet and drug therapy in patients with homozygous hypercholesterolemia.... Read More
category NYSE:SNY , NASDAQ:ISIS , NASDAQ:AEGR
from Forbes Real Time
Friday 1/25 Insider Buying Report: IHS, AEGR
January 25, 2013
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... Read More
category Stocks
from Market News Video
4 Biotechnology Stocks to Buy Now
January 16, 2013
 Read More
category NASDAQ:NVAX , NASDAQ:GENT , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Notable 52-Week Highs and Lows of the Day 01/11: (F) (AXP) (GGC) High; (BV) Low
January 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8003220 for the full story. Read More
from StreetInsider.com News Articles
Mid-Morning Market Update: Markets Heading Down, Dendreon Rockets Upwards
January 11, 2013
Following the market opening Friday, the Dow traded down 0.19 percent to 13,445.76 while the NASDAQ fell 0.22 percent to 3,114.98. The S&P also fell, decreasing 0.30 percent to 1,467.25. Top Headline... Read More
category Earnings , Benzinga , Movers , and 27 more.
from Latest Articles from Benzinga.com
Aegerion (AEGR) gains on new share offering
January 11, 2013
Normal 0 false false false MicrosoftInternetExplorer4 Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares vaulted 4.5% to $27.83, .after the biopharmaceutical company announced the pricing of an... Read More
from BAYSTREET RSS FEED
StreetInsider.com Pre-Open Movers 01/11: (INFY) (DNDN) (BBY) Higher; (ARQL) (KBR) (JCP) Lower (more...)
January 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8002634 for the full story. Read More
from StreetInsider.com News Articles
Aegerion Pharma (AEGR) Prices 2.7M Offering at $26.64/Share
January 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8002524 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 10/10: (UPIP) (AEGR) Higher; (KBR) (XRTX) (AXP) Lower (more...)
January 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8001850 for the full story. Read More
from StreetInsider.com News Articles
Aegerion Pharmaceuticals (AEGR) Plans Common Stock Offering
January 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8001497 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Aegerion Pharmaceuticals
January 09, 2013
In a report published Wednesday, Canaccord Genuity reiterated its Buy rating on Aegerion Pharmaceuticals (NASDAQ: AEGR ), and raised its price target from $27.00 to $36.00. Canaccord Genuity noted,... Read More
category US00767E1029 , Canaccord Genuity , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Aegerion Pharma (AEGR) Updates on JUXTAPID, Outlook for FY13
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7988994 for the full story. Read More
from StreetInsider.com News Articles
Aegerion Pharmaceuticals Grants Stock Options to Purchase 55K Shares
January 04, 2013
Aegerion Pharmaceuticals (NASDAQ: AEGR ), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often... Read More
category US00767E1029 , Management , Benzinga , and 3 more.
from Latest Articles from Benzinga.com
Fabulous Start to the Year
January 02, 2013
The stock market indices had a fabulous session to start the year, exploding with big breakaway gaps to the upside as a result of the fiscal cliff deal and relief in terms of a major relief rally. The... Read More
from Harry's Hotline by Harry Boxer
Janney Montgomery Scott Starts Aegerion Pharmaceuticals (AEGR) at Buy
January 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7978568 for the full story. Read More
from StreetInsider.com News Articles
Watson Pharmaceuticals, Inc and Other Big Movers In Healthcare on December 31, 2012
December 31, 2012
Currently, the Nasdaq has climbed 0.6%, the S&P 500 has risen 0.2% and the Dow has been relatively flat. The healthcare sector is the category of stocks relating to medical and healthcare goods or ser... Read More
from Investopedia Advisor Commentary
Analyst Moves: AEGR, DPZ
December 27, 2012
Aegerion Pharmaceuticals (AEGR) had its price target increased by Jefferies (JEF) to $29 with a buy rating, as the approval of Juxtapid should add to earnings. Shares are lower by about 1.2 percent. Read More
category Stocks
from Market News Video
UPDATE: Jefferies Raises PT to $29 on Aegerion Pharmaceuticals on Juxtapid Approval Outlook
December 27, 2012
Jefferies reiterated its Buy rating on Aegerion Pharmaceuticals (NASDAQ: AEGR ) and raised its price target from $24 to $29. Jefferies commented, "Juxtapid (lomitapide) approval for HoFH is in-line (EU... Read More
category US00767E1029 , Benzinga , AEGR , and 5 more.
from Latest Articles from Benzinga.com
Jefferies Boosts Target on Aegerion (AEGR) to $29 Ahead of Juxtapid Commercialization
December 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7970982 for the full story. Read More
from StreetInsider.com News Articles
Analyst Bullish as Aegerion (AEGR) Drug Approved with Broad Label
December 26, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7969659 for the full story. Read More
from StreetInsider.com News Articles
Intuitive Surgical Among Healthcare's Biggest Movers on December 26, 2012
December 26, 2012
The market is having a bad day so far: the Nasdaq has declined 1.1%; the S&P 500 is trading down 0.6%; and the Dow has fallen 0.3%. The healthcare sector is the category of stocks relating to medical... Read More
from Investopedia Advisor Commentary
Amazon.com Among the Nasdaq's Biggest Movers on December 26, 2012
December 26, 2012
The market is down this morning. The Nasdaq is trading down 1.1%; the S&P 500 is down 0.6%; and the Dow has slipped 0.3%. The Nasdaq Composite Index is a capitalization-weighted index, with each compa... Read More
from Investopedia Advisor Commentary
Stocks To Watch For December 26, 2012
December 26, 2012
Some of the stocks that may grab investor focus today are: Aegerion Pharmaceuticals (NASDAQ: AEGR ) reported that the US Food and Drug Administration approved its cholesterol drug. Aegerion shares fell... Read More
category US00767E1029 , Benzinga , LU0445408270 , and 12 more.
from Latest Articles from Benzinga.com
UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Aegerion Pharmaceuticals
December 24, 2012
In a report published Monday, J.P. Morgan & Co. reiterated its Overweight rating on Aegerion Pharmaceuticals (NASDAQ: AEGR ), and raised its price target from $28.00 to $30.00. J.P. Morgan noted, “We... Read More
category US00767E1029 , J/P/ Morgan & Co/ , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Markets Open Lower, Fiscal Cliff Talks on Hold
December 24, 2012
With negotiations to avert the fiscal cliff on hold, investors remained on the sidelines for a shortened Christmas Eve trading session with the Dow losing 31 points to 13,158. Nasdaq gave up 6 points... Read More
category Market News
from MarketMinute.com Market Updates
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here